Clostridioides difficile toxin is infrequently detected in inflammatory bowel disease and does not associate with clinical outcomes

INTRODUCTION: Clostridioides difficile infection (CDI) rates and outcomes can vary based on differences in testing strategy. Our aim was to assess the prevalence of toxin detection in inflammatory bowel disease (IBD) when compared to those without IBD. Secondly, the clinical outcomes of CDI in IBD w...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernard, Rachel, Hammami, Muhammad B., Arnold, Forest W., Mcgrath, Brian, Patel, Alieysa, Wuerth, Brandon, Nicholson, Maribeth R., Rao, Krishna, Micic, Dejan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426007/
https://www.ncbi.nlm.nih.gov/pubmed/36042530
http://dx.doi.org/10.1186/s13099-022-00511-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426007/
https://www.ncbi.nlm.nih.gov/pubmed/36042530
http://dx.doi.org/10.1186/s13099-022-00511-2

Ejemplares similares